Please login to the form below

Fishawack Health appoints Elizabeth Landon in the newly created Chief People Officer role

Elizabeth Landon brings exceptional leadership from a career supporting and scaling people-based businesses in the professional services and non-profit sectors.

22nd September 2021, Knutsford, UK. Fishawack Health, a leading commercialization partner for the life science industry, has appointed Elizabeth (Liz) Landon to a newly created executive role as Chief People Officer.

Liz’s appointment signals the next phase of Fishawack Health’s growth ambitions, focused on building and retaining talented teams, delivering an excellent employee experience, and providing the processes and infrastructure needed for the efficient and effective delivery of our suite of services.

Founded in 2001, Fishawack Health has more than 1,300 employees operating across 21 offices in Europe, the USA, and Asia, with a combined revenue of more than $230 million. The organization has designed a robust organic growth, talent development, and acquisition strategy to continuously build its team of the best-of-the-best medical, marketing and market access experts, delivering cutting-edge, end-to-end solutions for life science clients across the product lifecycle.

“We are thrilled to welcome Liz as Chief People Officer. Liz brings over 30 years of experience leading global Human Resources functions in professional services and people-based businesses” said Gail Flockhart, Fishawack Health Group President. “Her expertise and passion for developing people, from entry level to Executive Leadership, will ensure Fishawack Health attracts, retains, and develops the best talent while being the best place to work, learn, and grow in our industry. Liz has a rare blend of professional services and global human resource capability, which will weigh heavily in our organizational development as we move through this next phase of growth.”

Liz’s mission is to deliver a first-class employee experience from recruitment to hire, career progression, and exit.  She will lead an international team of HR, Talent, Diversity and Inclusion, and Learning and Development professionals in the design and delivery of talent, organizational effectiveness, operational, employee relations, and change management services for Fishawack Health’s U.S. and global businesses. Together, this approach will ensure that Fishawack Health balances the wellbeing, diversity, and development of our employees while growing the business in a fast-changing dynamic marketplace.

Liz has a Bachelor of Arts degree in Economics, an MBA, and a master’s degree in Public Policy –all from the University of Chicago. She started her career, spanning 25 years, at Accenture, a global consulting firm with over 500,000 employees. For the last 6 years, she has led Human Resources functions in the non-profit sector at the Lyric Opera of Chicago and then Heartland Alliance.

At Accenture, Liz was Global Managing Director for Talent Management, where she partnered with senior leadership to prioritize and scope global talent initiatives. During this time, she oversaw multiple dimensions of the organization’s workforce architecture, capability planning, and employee retention and engagement. She also spent a significant part of her career at Accenture in the Management Consulting practice, working on client and internal projects, focused on business strategy, organizational strategy, communications strategy, diversity and equity, human performance, and change management.

“I am excited to join Fishawack Health during this new phase of growth, which emphasizes its focus on the employee experience. I am looking forward to working alongside the Executive team to build a purpose-driven, agile, and future-facing organization that is global and scalable. As someone who has worked in the people function at a professional services company for a long period, I know how important it is to empower every employee to develop, grow, and thrive. Doing so will ensure we better deliver for our clients, patients, and healthcare professionals while ensuring that our employees’ experience and their development remains at the heart of everything we do,” Liz explains.

About Fishawack Health

Fishawack Health is the leading global commercialization partner for the modern life science era. Established in 2001 and headquartered in the UK, the organization is powered by a 1,300+ globe-spanning pack of strategic, creative, and scientific experts. We aim to drive change with healthcare professionals and affect patient lives.

Our core operating units ­– Medical, Market Access, Consulting, and Commercial – bring together best-in-class capabilities from around the world. We empower our clients in global pharmaceuticals, innovative biotech, and medical devices to navigate the most complex of ecosystems, helping them to navigate an efficient path to developing, launching, and growing their brands and portfolios.

Our internationally recognized, award-winning teams collaborate across operations in the UK (Brighton, Fleet, London, Knutsford, Manchester, Oxford, and Sale), Ireland (Dublin), USA (Chicago, Evansville, Minneapolis, New York, Philadelphia, San Diego, Scottsdale, and St. Louis), Greece (Athens), and Singapore.

Visit us at and follow us on Twitter and LinkedIn.


UK: Natasha Cowan

US: Elizabeth Mitchell

23rd September 2021



Company Details

Fishawack Health

+44 20 3328 1840

Contact Website

No. 3 Booths Park
Booths Hall
Chelford Road
WA16 8GS
United Kingdom

Latest content on this profile

The challenges of reimbursement and innovative pricing for cell and gene therapies
Our policy and market access experts at Avalere, part of Fishawack Health, share insights on the reimbursement challenges for cell and gene therapies and discuss the challenges and opportunities of innovative pricing models, including ensuring the model chosen meets the payer’s needs.
Fishawack Health
Digital therapeutics as a combination therapy: Maximizing asset value and therapeutic outcomes
Digital therapeutics can increase the value of medicinal assets, driving differentiation and improving outcomes for patients. But are manufacturers prepared to capitalize on this significant untapped opportunity before the tech giants dominate?
Fishawack Health
Fishawack Health welcomes Mario Muredda as its new President of Marketing
Fishawack Health (FH) ushers in a new era of data-driven omnichannel marketing with the hire of healthcare marketing veteran Mario Muredda.
Fishawack Health
5 ways we’re enhancing our services to support our clients in 2023
Fishawack Health CEO Jon Koch explains the new platforms, tools, and services we’re elevating to drive innovation for our clients in 2023.
Fishawack Health
Why it’s time to apply a payer lens to your early pipeline planning
Value, evidence, and market access experts Jan McKendrick and Andrea Hamlin reveal why applying a payer lens early in the value assessment of pipeline assets is essential for driving commercial success.
Fishawack Health
The fast-paced future of cell and gene therapies
In this report, we interview patients, researchers, and biopharmaceutical leaders to explore the complex landscape for the development of cell and gene therapies and share commercial recommendations from our specialist teams.
Fishawack Health